About BeneDoc
Helping medtech move at the speed of science—not bureaucracy
BeneDoc is the intelligence platform for medical-technology regulation. We connect the full record—FDA clearances, reimbursement, clinical evidence, and the market—so innovators can build a strategy from the first market read all the way to the submission.
How We Build
LLMs may achieve expert-level competency in long-document reasoning over enormous context windows—but that does not mean we should cut out human judgment. The stakes are too high when it comes to patient safety. Our platform is guided by three non-negotiable design principles.
AI is a power tool, not an autopilot.
We design around human-final workflows, automating the tedium so experts can spend their judgment where it matters. We expedite expertise rather than replace it.
The strictest guardrails belong in healthcare.
We constrain generative intelligence by grounding every output in the structured record—guidances, statutes, filings, and claims—so nothing is asserted that cannot be traced.
Everything traces back to its source.
Every pathway, predicate, requirement, and dollar links back to the FDA, CMS, or clinical record it came from. Strategy becomes evidence rather than opinion, and it stays auditable end to end.
Meet the Founders
Bryan Gilbert Davis, CEO
Former CTO and co-founder of Centari (Series A $14M). Bryan previously led ML and AI projects with teams of 4+ at Indeed, Meta, Nextdoor, and Tribe. He is a technical entrepreneur with expertise in architecting and scaling AI data pipelines.
Logan Stokols, Ph.D.
CTO. Mathematician (fluid dynamics, topologies) and technology entrepreneur. Former Research Professor at Duke University. Ph.D. in Mathematics from UT Austin.
Advisory Team
Dr. Jeffrey Stringer
Distinguished Professor at UNC School of Medicine. Founder of RealOB, a pioneering maternal health technology platform.
Sarah Dulson, Ph.D.
Regulatory Scientist at Rho. Ph.D. in Immunology with extensive experience in FDA submissions (INDs, NDAs, BLAs, 510(k)s, PMAs). Over a decade in regulatory affairs and clinical trial design.
Scott Alexander
Psychiatrist and founder of Astral Codex Ten (ACX). Supporter of innovative healthcare solutions and medical technology democratization through the ACX Grants program.
Jessica Mavadia-Shukla, Ph.D.
Principal Consultant at RS & HS Solutions, LLC. Director of Regulatory Strategy & Health Sciences at NuraLogix. Former Director of MDDT at CDRH, with 8+ years as an FDA regulatory reviewer.
Our Story
From Research to Reality
We watched strong, validated technology stall—not for lack of science, but for lack of a strategy that started early enough. We set out to make regulatory strategy a first-day, market-informed discipline.
Strategy starts on day one.
The pathway, the claims, the evidence, and the reimbursement are choices best made before the first line of code—not discovered at submission.
But the information was scattered.
Clearances, predicates, evidence bars, and payment lived in separate silos that no founder could assemble in time for it to matter.
So we connected the record.
We indexed the full CDRH corpus alongside CMS reimbursement, clinical trials, and patents into one queryable spine.
From market read to submission.
Today that spine powers an end-to-end strategy: pathway decision trees, competitor clearances, evidence, reimbursement, and the submission itself.
Our Vision
Compliance as Code. Innovation at Scale.
We envision a world where regulatory strategy is transparent, evidence-based, and available to every serious innovator—not just those who can afford a decade of institutional experience.
Minimize the bureaucracy, maximize the science.
In a truly rigorous system, building safely and documenting it can converge. We bridge that gap, turning compliance from an opaque process into transparent, machine-readable infrastructure.
The living record of compliance.
Regulatory reality is not static; it is a living history of clearances, guidances, precedent, and payment. We keep every signal current and legible, so decisions rest on what actually happened.
Regulatory intelligence earned by merit, not access.
We put the knowledge that used to live inside big-company regulatory teams in the hands of every innovator—so the best technology wins, not the deepest regulatory bench.
Our Core Mission
We're building the tools that help the next generation of medical-device innovators reach the market faster, and with less risk.
- 1
Simplify compliance
Transform regulatory work from an opaque process into transparent, machine-readable infrastructure.
- 2
Accelerate innovation
Help medtech teams move from concept to market faster, with strategy informed by the market from day one.
- 3
Enable better healthcare
By lowering the cost and risk of the path to market, we free innovators to focus on safer, more effective technology.